Stryker (SYK) Stock Price, News & Analysis

Company Overview

Stryker is a medical technology company that develops and sells products and services for healthcare providers. Its offerings include orthopedic implants and surgical equipment, neurotechnology and spine products, and medical and surgical equipment used in hospitals and other care settings.

The company’s products also include patient-handling and emergency medical equipment, as well as instruments and technologies that support surgical procedures. Stryker serves healthcare customers in the United States and internationally.

Founded in 1941 by orthopedic surgeon Dr. Homer Stryker, the company traces its roots to Kalamazoo, Michigan. It is now headquartered in Portage, Michigan.

Key Stats

• Today's Range: $315.37 to $320.70
• 50-Day Range: $269.98 to $340.40
• 52-Week Range: $267.00 to $389.33
• Volume: 3.22 million shs
• Average Volume: 3.22 million shs
• Market Capitalization: $121.31 billion
• P/E Ratio: 33.94
• Dividend Yield: 1.10%
• Price Target: $342.19
• Consensus Rating: Moderate Buy

Stryker Stock Analysis - MarketRank™

Stryker scored higher than 89% of companies evaluated by MarketBeat, and ranked 40th out of 896 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.0 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Stryker has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on no strong buy ratings, 21 buy ratings, 7 hold ratings, and no sell ratings.

Upside/Downside

The consensus price target for Stryker is close to its current price, suggesting limited near-term upside or downside.

Amount of Analyst Coverage

Stryker has been the subject of 22 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 9.36%

Earnings Growth

Earnings for Stryker are expected to grow by 9.36% in the coming year, from $14.85 to $16.24 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Stryker is 33.94, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.80.

Price to Earnings Ratio vs. Sector

The P/E ratio of Stryker is 33.94, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 34.16.

Price to Earnings Growth Ratio

Stryker has a PEG Ratio of 2.23. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Stryker has a P/B Ratio of 5.17. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.83% of the float of Stryker has been sold short.

Short Interest Ratio / Days to Cover

Stryker has a short interest ratio ("days to cover") of 2.23, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Stryker has recently increased by 16.84%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 4.2 / 5
• Dividend Strength: Strong

Dividend Yield

Stryker pays a meaningful dividend of 1.09%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Stryker has been increasing its dividend for 32 years.

Dividend Coverage

The dividend payout ratio of Stryker is 37.49%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Stryker will have a dividend payout ratio of 21.67% next year. This indicates that Stryker will be able to sustain or increase its dividend.

News and Social Media

• Score: 3.8 / 5
• News Sentiment: 1.10

News Sentiment

Stryker has a news sentiment score of 1.10. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.58 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 31 news articles for Stryker this week, compared to 8 articles on an average week.

Search Interest

Only 16 people have searched for SYK on MarketBeat in the last 30 days. This is a decrease of -47% compared to the previous 30 days.

MarketBeat Follows

13 people have added Stryker to their MarketBeat watchlist in the last 30 days. This is an increase of 333% compared to the previous 30 days.

Company Ownership

• Score: 1.6 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Stryker insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $297,123,701.00 in company stock.

Percentage Held by Insiders

4.60% of the stock of Stryker is held by insiders.

Percentage Held by Institutions

77.09% of the stock of Stryker is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Record date for 10/30 Dividend: 9/30/2026
• Ex-Dividend for 10/30 Dividend: 9/30/2026
• Last Earnings: 10/29/2026
• Dividend Payable: 10/30/2026
• Today: 11/12/2026
• Jefferies Global Healthcare Conference: 11/17/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NYSE:SYK
• CIK: 310764
• Web: www.stryker.com
• Phone: (269) 385-2600
• Fax: 269-385-1062
• Employees: 56,000
• Year Founded: 1941

Price Target and Rating

• Average Price Target for Stryker: $342.19
• High Price Target: $405.00
• Low Price Target: $275.00
• Potential Upside/Downside: +7.4%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.75
• Research Coverage: 28 Analysts

Profitability

• EPS (Trailing Twelve Months): $9.39
• Trailing P/E Ratio: 33.94
• Forward P/E Ratio: 19.62
• P/E Growth: 2.23
• Net Income: $3.25 billion
• Net Margins: 13.78%
• Pretax Margin: 19.45%
• Return on Equity: 23.74%
• Return on Assets: 11.64%

Debt

• Debt-to-Equity Ratio: 0.60
• Current Ratio: 2.18
• Quick Ratio: 1.30

Sales & Book Value

• Annual Sales: $25.12 billion
• Price / Sales: 4.83
• Cash Flow: $16.60 per share
• Price / Cash Flow: 19.20
• Book Value: $61.62 per share
• Price / Book: 5.17

Miscellaneous

• Outstanding Shares: 380,690,000
• Free Float: 363,179,000
• Market Cap: $121.31 billion
• Optionable: Optionable
• Beta: 0.78